TBX1 and chondrosarcoma: Moreover, all tumor specimens were tested for Brachyury, a marker highly specific for chordomas, which nearly eliminates the risk of inadvertent inclusion of chondrosarcomas with a lower risk for local recurrence after particle treatment.